Iwaki Co., Ltd. (TYO:6237)
2,663.00
-36.00 (-1.33%)
At close: Jan 23, 2026
Iwaki Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| 45,916 | 45,763 | 44,539 | 37,730 | 32,439 | 28,162 | Upgrade | |
Revenue Growth (YoY) | 2.85% | 2.75% | 18.05% | 16.31% | 15.19% | -1.65% | Upgrade |
Cost of Revenue | 27,534 | 27,265 | 26,211 | 24,807 | 21,411 | 18,459 | Upgrade |
Gross Profit | 18,382 | 18,498 | 18,328 | 12,923 | 11,028 | 9,703 | Upgrade |
Selling, General & Admin | 12,284 | 12,354 | 12,570 | 10,323 | 8,782 | 7,957 | Upgrade |
Amortization of Goodwill & Intangibles | 298 | 298 | 277 | 145 | 83 | 39 | Upgrade |
Operating Expenses | 12,583 | 12,653 | 12,862 | 10,480 | 8,889 | 7,996 | Upgrade |
Operating Income | 5,799 | 5,845 | 5,466 | 2,443 | 2,139 | 1,707 | Upgrade |
Interest Expense | -79 | -83 | -79 | -38 | -17 | -24 | Upgrade |
Interest & Investment Income | 171 | 175 | 112 | 48 | 19 | 29 | Upgrade |
Earnings From Equity Investments | 556 | 488 | 536 | 1,020 | 801 | 509 | Upgrade |
Currency Exchange Gain (Loss) | 46 | -19 | 57 | 77 | 38 | -23 | Upgrade |
Other Non Operating Income (Expenses) | 151 | 110 | 129 | 381 | 11 | 23 | Upgrade |
EBT Excluding Unusual Items | 6,644 | 6,516 | 6,221 | 3,931 | 2,991 | 2,221 | Upgrade |
Gain (Loss) on Sale of Investments | 12 | 22 | 4 | 1,234 | 140 | 381 | Upgrade |
Gain (Loss) on Sale of Assets | - | - | 1 | 1 | - | - | Upgrade |
Asset Writedown | -14 | -17 | -52 | -2 | -10 | -7 | Upgrade |
Legal Settlements | - | - | - | - | -55 | - | Upgrade |
Other Unusual Items | 3 | 2 | - | - | 40 | - | Upgrade |
Pretax Income | 6,645 | 6,523 | 6,174 | 5,164 | 3,106 | 2,595 | Upgrade |
Income Tax Expense | 1,951 | 1,932 | 1,582 | 728 | 691 | 496 | Upgrade |
Earnings From Continuing Operations | 4,694 | 4,591 | 4,592 | 4,436 | 2,415 | 2,099 | Upgrade |
Minority Interest in Earnings | -100 | -123 | -133 | -38 | -19 | -8 | Upgrade |
Net Income | 4,594 | 4,468 | 4,459 | 4,398 | 2,396 | 2,091 | Upgrade |
Net Income to Common | 4,594 | 4,468 | 4,459 | 4,398 | 2,396 | 2,091 | Upgrade |
Net Income Growth | 3.38% | 0.20% | 1.39% | 83.56% | 14.59% | -1.46% | Upgrade |
Shares Outstanding (Basic) | 22 | 22 | 22 | 22 | 22 | 22 | Upgrade |
Shares Outstanding (Diluted) | 22 | 22 | 22 | 22 | 22 | 22 | Upgrade |
Shares Change (YoY) | 0.21% | 0.27% | 0.41% | 0.19% | -0.55% | -0.28% | Upgrade |
EPS (Basic) | 207.58 | 202.14 | 202.28 | 200.32 | 109.34 | 94.89 | Upgrade |
EPS (Diluted) | 207.58 | 202.14 | 202.28 | 200.32 | 109.34 | 94.89 | Upgrade |
EPS Growth | 3.16% | -0.07% | 0.98% | 83.21% | 15.22% | -1.19% | Upgrade |
Free Cash Flow | 1,810 | 2,697 | 1,480 | 620 | 2,083 | 1,496 | Upgrade |
Free Cash Flow Per Share | 81.78 | 122.02 | 67.14 | 28.24 | 95.06 | 67.89 | Upgrade |
Dividend Per Share | 73.000 | 63.000 | 62.000 | 61.000 | 33.500 | 29.000 | Upgrade |
Dividend Growth | 10.61% | 1.61% | 1.64% | 82.09% | 15.52% | -4.92% | Upgrade |
Gross Margin | 40.03% | 40.42% | 41.15% | 34.25% | 34.00% | 34.45% | Upgrade |
Operating Margin | 12.63% | 12.77% | 12.27% | 6.48% | 6.59% | 6.06% | Upgrade |
Profit Margin | 10.01% | 9.76% | 10.01% | 11.66% | 7.39% | 7.42% | Upgrade |
Free Cash Flow Margin | 3.94% | 5.89% | 3.32% | 1.64% | 6.42% | 5.31% | Upgrade |
EBITDA | 7,331 | 7,390 | 7,166 | 3,511 | 2,981 | 2,471 | Upgrade |
EBITDA Margin | 15.97% | 16.15% | 16.09% | 9.31% | 9.19% | 8.77% | Upgrade |
D&A For EBITDA | 1,532 | 1,545 | 1,700 | 1,068 | 842 | 764 | Upgrade |
EBIT | 5,799 | 5,845 | 5,466 | 2,443 | 2,139 | 1,707 | Upgrade |
EBIT Margin | 12.63% | 12.77% | 12.27% | 6.48% | 6.59% | 6.06% | Upgrade |
Effective Tax Rate | 29.36% | 29.62% | 25.62% | 14.10% | 22.25% | 19.11% | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.